Mitochondria as Therapeutic Targets for the Treatment of Malignant Disease
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mitochondria as Therapeutic Targets for the Treatment of Malignant Disease
Authors
Keywords
-
Journal
ANTIOXIDANTS & REDOX SIGNALING
Volume 15, Issue 12, Pages 2937-2949
Publisher
Mary Ann Liebert Inc
Online
2011-06-07
DOI
10.1089/ars.2011.4078
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mitochondrial targeting of α-tocopheryl succinate enhances its pro-apoptotic efficacy: A new paradigm for effective cancer therapy
- (2011) Lan-Feng Dong et al. FREE RADICAL BIOLOGY AND MEDICINE
- Hypoxic human cancer cells are sensitized to BH-3 mimetic–induced apoptosis via downregulation of the Bcl-2 protein Mcl-1
- (2011) Luke R.E. Harrison et al. JOURNAL OF CLINICAL INVESTIGATION
- Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity
- (2011) R. Dash et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- α-Tocopheryl succinate causes mitochondrial permeabilization by preferential formation of Bak channels
- (2010) Lubomir Prochazka et al. APOPTOSIS
- Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1
- (2010) D. Yecies et al. BLOOD
- Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens
- (2010) P. Montesinos et al. BLOOD
- The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo
- (2010) Scott Ackler et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies
- (2010) Paul K. Paik et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A Bax-Mediated Mechanism for Obatoclax-Induced Apoptosis of Cholangiocarcinoma Cells
- (2010) R. L. Smoot et al. CANCER RESEARCH
- Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
- (2010) I. Ben Sahra et al. CANCER RESEARCH
- Mitochondrial Targeting of Vitamin E Succinate Enhances Its Pro-apoptotic and Anti-cancer Activity via Mitochondrial Complex II
- (2010) Lan-Feng Dong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance
- (2010) Laura Bonapace et al. JOURNAL OF CLINICAL INVESTIGATION
- Gossypol Induces Apoptosis by Activating p53 in Prostate Cancer Cells and Prostate Tumor-Initiating Cells
- (2010) S. R. Volate et al. MOLECULAR CANCER THERAPEUTICS
- Identification of Expression Signatures Predictive of Sensitivity to the Bcl-2 Family Member Inhibitor ABT-263 in Small Cell Lung Carcinoma and Leukemia/Lymphoma Cell Lines
- (2010) S. K. Tahir et al. MOLECULAR CANCER THERAPEUTICS
- Molecular mechanisms of necroptosis: an ordered cellular explosion
- (2010) Peter Vandenabeele et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Metabolic Modulation of Glioblastoma with Dichloroacetate
- (2010) E. D. Michelakis et al. Science Translational Medicine
- GX15-070 (obatoclax) overcomes glucocorticoid resistance in acute lymphoblastic leukemia through induction of apoptosis and autophagy
- (2010) N Heidari et al. Cell Death & Disease
- Resveratrol: Its Biologic Targets and Functional Activity
- (2009) Shazib Pervaiz et al. ANTIOXIDANTS & REDOX SIGNALING
- Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo
- (2009) Ramon C. Sun et al. BREAST CANCER RESEARCH AND TREATMENT
- Mitochondria-Penetrating Peptides: Sequence Effects and Model Cargo Transport
- (2009) Lema F. Yousif et al. CHEMBIOCHEM
- Targeting Mitochondria with Organelle-Specific Compounds: Strategies and Applications
- (2009) Lema F. Yousif et al. CHEMBIOCHEM
- An Open-Label, Multicenter, Phase I/II Study of Single-Agent AT-101 in Men with Castrate-Resistant Prostate Cancer
- (2009) G. Liu et al. CLINICAL CANCER RESEARCH
- Targeting mitochondrial apoptosis by betulinic acid in human cancers
- (2009) Simone Fulda et al. DRUG DISCOVERY TODAY
- Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction
- (2009) Ismael Samudio et al. JOURNAL OF CLINICAL INVESTIGATION
- The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia
- (2009) K D Mason et al. LEUKEMIA
- Inhibition of Fatty Acid Synthase by Orlistat Accelerates Gastric Tumor Cell Apoptosis in Culture and Increases Survival Rates in Gastric Tumor Bearing Mice In Vivo
- (2009) Shawn Dowling et al. LIPIDS
- Bim Upregulation by Histone Deacetylase Inhibitors Mediates Interactions with the Bcl-2 Antagonist ABT-737: Evidence for Distinct Roles for Bcl-2, Bcl-xL, and Mcl-1
- (2009) S. Chen et al. MOLECULAR AND CELLULAR BIOLOGY
- The Bcl-2 Homology Domain 3 Mimetic ABT-737 Targets the Apoptotic Machinery in Acute Lymphoblastic Leukemia Resulting in Synergistic in Vitro and in Vivo Interactions with Established Drugs
- (2009) L. M. High et al. MOLECULAR PHARMACOLOGY
- Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
- (2009) Martin Schwickart et al. NATURE
- Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow--a long-term follow-up
- (2008) I. J. Diel et al. ANNALS OF ONCOLOGY
- Development of mitochondria-targeted derivatives of resveratrol
- (2008) Lucia Biasutto et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048)
- (2008) S. Kitada et al. BLOOD
- Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors
- (2008) K. F. Whitecross et al. BLOOD
- Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia
- (2008) S. M. O'Brien et al. BLOOD
- The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies
- (2008) L. Paoluzzi et al. BLOOD
- BH3 Mimetic ABT-737 Potentiates TRAIL-Mediated Apoptotic Signaling by Unsequestering Bim and Bak in Human Pancreatic Cancer Cells
- (2008) S. Huang et al. CANCER RESEARCH
- ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
- (2008) C. Tse et al. CANCER RESEARCH
- Alteration of the Mitochondrial Apoptotic Pathway Is Key to Acquired Paclitaxel Resistance and Can Be Reversed by ABT-737
- (2008) O. Kutuk et al. CANCER RESEARCH
- Therapeutic Efficacy of ABT-737, a Selective Inhibitor of BCL-2, in Small Cell Lung Cancer
- (2008) C. L. Hann et al. CANCER RESEARCH
- A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies
- (2008) A. D. Schimmer et al. CLINICAL CANCER RESEARCH
- BH3 Mimetic Obatoclax Enhances TRAIL-Mediated Apoptosis in Human Pancreatic Cancer Cells
- (2008) S. Huang et al. CLINICAL CANCER RESEARCH
- Dichloroacetate induces apoptosis in endometrial cancer cells
- (2008) Jason Y.Y. Wong et al. GYNECOLOGIC ONCOLOGY
- Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model
- (2008) Marco A. Carvalho et al. INTERNATIONAL JOURNAL OF CANCER
- Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs
- (2008) Constantina Constantinou et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor resistance to apoptosis
- (2008) Simone Fulda INTERNATIONAL JOURNAL OF CANCER
- ABT-737 Induces Expression of the Death Receptor 5 and Sensitizes Human Cancer Cells to TRAIL-induced Apoptosis
- (2008) Jin H. Song et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Fatty-acid Synthase Induces Caspase-8-mediated Tumor Cell Apoptosis by Up-regulating DDIT4
- (2008) Lynn M. Knowles et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy
- (2008) Asfar S. Azmi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic
- (2008) Mark S. Cragg et al. JOURNAL OF CLINICAL INVESTIGATION
- BH3 Mimetic ABT-737 and a Proteasome Inhibitor Synergistically Kill Melanomas through Noxa-Dependent Apoptosis
- (2008) Leslie A. Miller et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Measuring apoptosis at the single cell level
- (2008) Lisa Bouchier-Hayes et al. METHODS
- Methyl jasmonate binds to and detaches mitochondria-bound hexokinase
- (2008) N Goldin et al. ONCOGENE
- α-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II
- (2008) L-F Dong et al. ONCOGENE
- Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
- (2008) K E Tagscherer et al. ONCOGENE
- In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas
- (2008) K. D. Mason et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling
- (2008) J. C. Juarez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dichloroacetate (DCA) sensitizes both wild‐type and over expressingBcl‐2prostate cancer cells in vitro to radiation
- (2008) Wengang Cao et al. PROSTATE
- Cytotoxic activity of 3,3′,4,4′,5,5′-hexahydroxystilbene against breast cancer cells is mediated by induction of p53 and downregulation of mitochondrial superoxide dismutase
- (2008) Marek Murias et al. TOXICOLOGY IN VITRO
- Mitochondria in cancer cells: what is so special about them?
- (2008) Vladimir Gogvadze et al. TRENDS IN CELL BIOLOGY
- MITO-Porter: A liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion
- (2007) Yuma Yamada et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Initial testing (stage 1) of the BH3 mimetic ABT-263 by the pediatric preclinical testing program
- (2007) Richard Lock et al. PEDIATRIC BLOOD & CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More